Recon: FDA and Biogen’s Aduhelm back channel; FDA rejects MediWound burn treatment
ReconMichael Mezher
BiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesPharmaceuticalsReconMichael MezherBiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesPharmaceuticals